These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 21864245)

  • 1. Synthesis of [64Cu]Cu-NOTA-Bn-GE11 for PET imaging of EGFR-rich tumors.
    Dejesus OT
    Curr Radiopharm; 2012 Jan; 5(1):15-8. PubMed ID: 21864245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring pitfalls of
    Striese F; Sihver W; Gao F; Bergmann R; Walther M; Pietzsch J; Steinbach J; Pietzsch HJ
    Amino Acids; 2018 Oct; 50(10):1415-1431. PubMed ID: 30039310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and Analysis of
    Paiva I; Mattingly S; Wuest M; Leier S; Vakili MR; Weinfeld M; Lavasanifar A; Wuest F
    Mol Pharm; 2020 May; 17(5):1470-1481. PubMed ID: 32233491
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Chen CJ; Chan CH; Lin KL; Chen JH; Tseng CH; Wang PY; Chien CY; Yu HM; Lin WJ
    Nucl Med Biol; 2019; 68-69():22-30. PubMed ID: 30578136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrin α
    Li H; Peng W; Zhen Z; Zhang W; Liao S; Wu X; Wang L; Xuan A; Gao Y; Xu J
    Nucl Med Biol; 2023; 124-125():108364. PubMed ID: 37591041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of (68)Ga-labeled NOTA-RGD-GE11 heterodimeric peptide for dual integrin and epidermal growth factor receptor-targeted tumor imaging.
    Yu HM; Chen JH; Lin KL; Lin WJ
    J Labelled Comp Radiopharm; 2015 Jun; 58(7):299-303. PubMed ID: 25997858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and evaluation of [
    Li X; Hu K; Liu W; Wei Y; Sha R; Long Y; Han Y; Sun P; Wu H; Li G; Tang G; Huang S
    Nucl Med Biol; 2020; 90-91():84-92. PubMed ID: 33189948
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Pyo A; Yun M; Kim HS; Kim TY; Lee JJ; Kim JY; Lee S; Kwon SY; Bom HS; Kim HS; Kim DY; Min JJ
    J Nucl Med; 2018 Feb; 59(2):340-346. PubMed ID: 28916621
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Kwon LY; Scollard DA; Reilly RM
    Mol Pharm; 2017 Feb; 14(2):492-501. PubMed ID: 28049295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroPET/CT imaging of patient-derived pancreatic cancer xenografts implanted subcutaneously or orthotopically in NOD-scid mice using (64)Cu-NOTA-panitumumab F(ab')2 fragments.
    Boyle AJ; Cao PJ; Hedley DW; Sidhu SS; Winnik MA; Reilly RM
    Nucl Med Biol; 2015 Feb; 42(2):71-7. PubMed ID: 25456837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PET Imaging of VEGFR-2 Expression in Lung Cancer with 64Cu-Labeled Ramucirumab.
    Luo H; England CG; Graves SA; Sun H; Liu G; Nickles RJ; Cai W
    J Nucl Med; 2016 Feb; 57(2):285-90. PubMed ID: 26541778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and comparative evaluation of novel (64)Cu-labeled high affinity cell-specific peptides for positron emission tomography imaging of tumor vasculature.
    Merrill JR; Krajewski K; Yuan H; Frank JE; Lalush DS; Patterson C; Veleva AN
    Biomaterials; 2016 Apr; 84():241-249. PubMed ID: 26839954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular imaging of cancer with copper-64 radiopharmaceuticals and positron emission tomography (PET).
    Shokeen M; Anderson CJ
    Acc Chem Res; 2009 Jul; 42(7):832-41. PubMed ID: 19530674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Challenges for the application of EGFR-targeting peptide GE11 in tumor diagnosis and treatment.
    Hailing T; Yonghong P; Yufeng Z; Haitao T
    J Control Release; 2022 Sep; 349():592-605. PubMed ID: 35872181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small-animal PET imaging of human epidermal growth factor receptor positive tumor with a 64Cu labeled affibody protein.
    Miao Z; Ren G; Liu H; Jiang L; Cheng Z
    Bioconjug Chem; 2010 May; 21(5):947-54. PubMed ID: 20402512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Folate-PEG-NOTA-Al
    Chen Q; Meng X; McQuade P; Rubins D; Lin SA; Zeng Z; Haley H; Miller P; González Trotter D; Low PS
    Mol Pharm; 2017 Dec; 14(12):4353-4361. PubMed ID: 29028357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immuno-PET Imaging and Radioimmunotherapy of 64Cu-/177Lu-Labeled Anti-EGFR Antibody in Esophageal Squamous Cell Carcinoma Model.
    Song IH; Lee TS; Park YS; Lee JS; Lee BC; Moon BS; An GI; Lee HW; Kim KI; Lee YJ; Kang JH; Lim SM
    J Nucl Med; 2016 Jul; 57(7):1105-11. PubMed ID: 26917708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of a novel
    Jiao H; Zhao X; Han J; Zhang J; Wang J
    Int J Radiat Biol; 2020 Nov; 96(11):1443-1451. PubMed ID: 32809887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-terminal modifications improve the receptor affinity and pharmacokinetics of radiolabeled peptidic gastrin-releasing peptide receptor antagonists: examples of 68Ga- and 64Cu-labeled peptides for PET imaging.
    Gourni E; Mansi R; Jamous M; Waser B; Smerling C; Burian A; Buchegger F; Reubi JC; Maecke HR
    J Nucl Med; 2014 Oct; 55(10):1719-25. PubMed ID: 25146125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PET Imaging of Tissue Factor in Pancreatic Cancer Using 64Cu-Labeled Active Site-Inhibited Factor VII.
    Nielsen CH; Jeppesen TE; Kristensen LK; Jensen MM; El Ali HH; Madsen J; Wiinberg B; Petersen LC; Kjaer A
    J Nucl Med; 2016 Jul; 57(7):1112-9. PubMed ID: 27013699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.